Monumental Financial Group’s Pfizer PFE Stock Holding History

Monumental Financial Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,051	Closed	-$473K	–	109
2021 Q1	$473K	Buy	+13,051	New	+$463K	0.45%	41

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Monumental Financial Group's PFE Position: Q2 2021 in Review

Monumental Financial Group sold out of Pfizer (PFE) in Q2 2021, closing a stake of 13,051 shares — an estimated $473K sold.

Monumental Financial Group first reported a position in PFE in Q1 2021 and held it in 1 quarter. The position peaked at $473K in Q1 2021. 2,735 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

Monumental Financial Group reported no remaining Pfizer position as of Q2 2021 after selling out during the quarter.
Monumental Financial Group sold 13,051 Pfizer shares in Q2 2021, an estimated $473K.
Monumental Financial Group first reported a position in Pfizer in Q1 2021 and held it in 1 quarter.
Monumental Financial Group's Pfizer position peaked at $473K in Q1 2021.
2,735 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Monumental Financial Group's 13F filing for Q2 2021, filed 12 Aug 2021.